再鼎医药盘中异动早盘股价大跌5.01%报16.39美元

自选股智能写手08-09

北京时间2024年08月09日21时31分，再鼎医药（ZLAB.us）股票出现波动，股价急速下挫5.01%。截至发稿，该股报16.39美元/股，成交量6404股，换手率0.01%，振幅2.38%。最近的财报数据显示，该股实现营业收入1.01亿美元，净利润-80.28百万美元，每股收益-0.82美元，毛利65.27百万美元，市盈率-5.41倍。机构评级方面，在所有13家参与评级的机构中，92%的券商...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2458559985?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-09 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2458559985","market":"us","top_or_hot":-1,"title":"再鼎医药盘中异动 早盘股价大跌5.01%报16.39美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月09日21时31分，再鼎医药（ZLAB.us）股票出现波动，股价急速下挫5.01%。截至发稿，该股报16.39美元/股，成交量6404股，换手率0.01%，振幅2.38%。最近的财报数据显示，该股实现营业收入1.01亿美元，净利润-80.28百万美元，每股收益-0.82美元，毛利65.27百万美元，市盈率-5.41倍。机构评级方面，在所有13家参与评级的机构中，92%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213134aefe259c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>再鼎医药盘中异动 早盘股价大跌5.01%报16.39美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n再鼎医药盘中异动 早盘股价大跌5.01%报16.39美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-09 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213134aefe259c&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月09日21时31分，再鼎医药（ZLAB.us）股票出现波动，股价急速下挫5.01%。截至发稿，该股报16.39美元/股，成交量6404股，换手率0.01%，振幅2.38%。最近的财报数据显示，该股实现营业收入1.01亿美元，净利润-80.28百万美元，每股收益-0.82美元，毛利65.27百万美元，市盈率-5.41倍。机构评级方面，在所有13家参与评级的机构中，92%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213134aefe259c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4531","symbol_name":"中概回港概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213134aefe259c&s=b","article_id":"2458559985","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213134aefe259c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2458559985","pubTimestamp":1723210294,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"截至发稿，该股报16.39美元/股，成交量6404股，换手率0.01%，振幅2.38%。机构评级方面，在所有13家参与评级的机构中，92%的券商给予买入建议，8%的券商给予持有建议，无券商给予卖出建议。再鼎医药股票所在的生物技术行业中，整体涨幅为0.32%。消息层面，截至21时31分，再鼎医药股票正面舆情新闻比例22.86%。《大行评级｜美银：上调再鼎医药目标价至19.38港元 维持“买入”评级》资讯为影响再鼎医药的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4531":"中概回港概念","ZLAB":"再鼎医药","BK4585":"ETF&股票定投概念","BK4526":"热门中概股","BK4588":"碎股","BK4139":"生物科技","BK4548":"巴美列捷福持仓"},"translate_title":"Zai Lab's intraday changes, shares fell 5.01% to $16.39 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZLAB":1},"content_text":"北京时间2024年08月09日21时31分，再鼎医药（ZLAB.us）股票出现波动，股价急速下挫5.01%。截至发稿，该股报16.39美元/股，成交量6404股，换手率0.01%，振幅2.38%。最近的财报数据显示，该股实现营业收入1.01亿美元，净利润-80.28百万美元，每股收益-0.82美元，毛利65.27百万美元，市盈率-5.41倍。机构评级方面，在所有13家参与评级的机构中，92%的券商给予买入建议，8%的券商给予持有建议，无券商给予卖出建议。再鼎医药股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为32.77%、5.41%、4.90%，振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Enliven Therapeutics, Inc.、Relmada Therapeutics, Inc.，振幅分别为10.21%、9.58%、9.57%。再鼎医药公司简介：再鼎医药有限公司是一家生物制药公司，专注于发现或许可、开发和商业化专利疗法，以解决未满足的医疗需求领域，包括肿瘤、自身免疫和传染病领域。 该公司的专利候选药物管线包括：ZL-2306，用于治疗包括卵巢癌和某些类型的乳腺癌和肺癌在内的多种实体瘤类型； ZL-2401，一类新型四环素衍生物中的抗生素； ZL-2301，一种靶向HCC的口服小分子药物。消息层面，截至21时31分，再鼎医药股票正面舆情新闻比例22.86%。《大行评级｜美银：上调再鼎医药目标价至19.38港元 维持“买入”评级》资讯为影响再鼎医药的重要信息。该信息摘要如下：格隆汇8月9日｜美银证券发表报告指，再鼎医药次季商业化表现稳健，由于销售表现稳健，且研发进度如期推进，目标价由16.28港元升至19.38港元，维持“买入”评级。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458559985"}

再鼎医药盘中异动 早盘股价大跌5.01%报16.39美元

精彩评论

再鼎医药盘中异动早盘股价大跌5.01%报16.39美元